5.92
price up icon2.60%   +0.15
after-market  アフターアワーズ:  5.925  0.005   +0.08%
loading

TriSalus Life Sciences Inc (TLSI) 最新ニュース

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 140.2% in May - MarketBeat

pulisher
MarketBeat

Clear Street LLC Invests $60000 in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) - Defense World

pulisher
Defense World

TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via ... - Business Wire

pulisher
Business Wire

TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World

pulisher
Defense World

TriSalus Life Sciences (NASDAQ:TLSI) Earns Buy Rating from Analysts at Canaccord Genuity Group - MarketBeat

pulisher
MarketBeat

Canaccord Genuity upbeat on TriSalus stock, cites innovative oncology treatments By Investing.com - Investing.com

pulisher
Investing.com

Canaccord Genuity upbeat on TriSalus stock, cites innovative oncology treatments - Investing.com India

pulisher
Investing.com India

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) Short Interest Update - Defense World

pulisher
Defense World

TriSalus Life Sciences Inc (TLSI) Stock: A Comprehensive 52-Week Review - The InvestChronicle

pulisher
The InvestChronicle

Analysts' Revisions Show Improving Sentiment For TriSalus Life Sciences Inc (NASDAQ: TLSI) – Stocks Register - Stocks Register

pulisher
Stocks Register

Investor's Toolkit: Key Ratios for Assessing TriSalus Life Sciences Inc (TLSI)'s Performance – DWinneX - The Dwinnex

pulisher
The Dwinnex

TriSalus Life Sciences launches exchange offer for warrants By Investing.com - Investing.com

pulisher
Investing.com

TriSalus Life Sciences launches exchange offer for warrants - Investing.com South Africa

pulisher
Investing.com South Africa

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants - Business Wire

pulisher
Business Wire

TriSalus Life Sciences launches exchange offer for warrants By Investing.com - Investing.com

pulisher
Investing.com

Fractyl Health (NASDAQ:GUTS) versus TriSalus Life Sciences (NASDAQ:TLSI) Head-To-Head Review - Defense World

pulisher
Defense World

Navigating the Financial Tightrope: Trisalus Life Sciences' High-Stakes Debt Strategy with OrbiMed - TipRanks.com - TipRanks

pulisher
TipRanks

TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Earnings Call Transcript - Seeking Alpha

pulisher
Seeking Alpha

TriSalus Reports Q1 2024 Financial Results and Business Update - Manchestertimes

pulisher
Manchestertimes

TriSalus Reports Q1 2024 Financial Results and Business Update - Business Wire

pulisher
Business Wire

TriSalus Reports Q1 2024 Financial Results and Business Update - Yahoo Finance

pulisher
Yahoo Finance

TriSalus Life Sciences (NASDAQ:TLSI) Research Coverage Started at Jonestrading - Defense World

pulisher
Defense World

TriSalus shares gain as Jones Trading sets price target - Investing.com

pulisher
Investing.com

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Down 38.6% in April - MarketBeat

pulisher
MarketBeat

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Down 38.6% in April - MarketBeat

pulisher
MarketBeat

TriSalus shares gain as Jones Trading sets price target By Investing.com - Investing.com

pulisher
Investing.com

TriSalus Life Sciences appoints new board member By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Uveal Melanoma Market Is Expected to Showcase a Significant Growth During the Forecast Period - openPR

pulisher
openPR

TriSalus Life Sciences Expands Board, Welcomes Liselotte Hyveled - TipRanks.com - TipRanks

pulisher
TipRanks

TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors - Business Wire

pulisher
Business Wire

TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors - Business Wire

pulisher
Business Wire

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call - Winchester Herald Chronicle

pulisher
Winchester Herald Chronicle

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call - Business Wire

pulisher
Business Wire

InspireMD (NYSE:NSPR) vs. TriSalus Life Sciences (NASDAQ:TLSI) Head to Head Comparison - Defense World

pulisher
Defense World

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call - Yahoo Finance

pulisher
Yahoo Finance

Analyzing TriSalus Life Sciences (NASDAQ:TLSI) & Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) - Defense World

pulisher
Defense World

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System ... - Manchestertimes

pulisher
Manchestertimes

TriSalus Life Sciences Secures $50 Million Loan Facility - TipRanks.com - TipRanks

pulisher
TipRanks

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System ... - Business Wire

pulisher
Business Wire

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

TriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ... - Yahoo Finance

pulisher
Yahoo Finance

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 ... - Yahoo Finance

pulisher
Yahoo Finance

TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association's ... - Business Wire

pulisher
Business Wire

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients ... - Yahoo Finance

pulisher
Yahoo Finance

Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the ... - PR Newswire

pulisher
PR Newswire

TriSalus Life Sciences Announces CMS Reimbursement for the TriNav® Infusion System via Assignment of a New ... - Business Wire

pulisher
Business Wire

Westminster oncology company holds first earnings call since going public - Denver Business Journal

pulisher
Denver Business Journal

TriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference Call - Business Wire

pulisher
Business Wire

Foley Advises MedTech in Merger with TriSalus Life Sciences - Foley & Lardner LLP

pulisher
Foley & Lardner LLP

TriSalus merges with MedTech Acquisition to bolster cash reserves - Pharmaceutical Technology

pulisher
Pharmaceutical Technology
$245.52
price down icon 4.10%
medical_devices STE
$216.12
price down icon 0.99%
medical_devices ZBH
$107.03
price down icon 0.15%
medical_devices PHG
$25.59
price down icon 0.39%
$116.53
price up icon 0.50%
medical_devices EW
$86.87
price down icon 0.48%
大文字化:     |  ボリューム (24 時間):